View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200, Head and Neck Tumors, adjuvant, cycle 6-17
Protocol-ID: 2972 V1.0 (Mini), PEMB200, Head and Neck Tumors, adj., C6-17Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.07.2025